Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Molecular and Cellular Neurosciences|July 20, 2001
Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factorsA M Hartmann, D Rujescu, T Giannakouros, et al.
International Angiology : a Journal of the International Union of Angiology|June 10, 2006
Early vascular lesions in subjects with metabolic syndrome and prediabetesE J Diamantopoulos, E A Andreadis, G I Tsourous, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 5, 2008
The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos studyE A Andreadis, P M Katsanou, D X Georgiopoulos, et al.
The American Review of Respiratory Disease|January 1, 1988
Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndromeJ W Cox, N A Andreadis, R C Bone, et al.
Journal of Human Hypertension|March 11, 2005
High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertensionE A Andreadis, G I Tsourous, G E Marakomichelakis, et al.
Diabetes & Metabolism|October 31, 2020
Diabetes mellitus in the era of climate changeNatalia G Vallianou, Eleni V Geladari, Dimitris Kounatidis, et al.
Journal of Hypertension|August 16, 2019
Ambulatory versus home blood pressure monitoring: frequency and determinants of blood pressure difference and diagnostic disagreementAngeliki Ntineri, Teemu J Niiranen, Richard J McManus, et al.
American Journal of Hypertension|May 23, 2000
Distribution of different HLA antigens in Greek hypertensives according to the angiotensin-converting enzyme genotypeE J Diamantopoulos, E A Andreadis, C V Vassilopoulos, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|February 25, 2003
Increased plasma plasminogen activator inhibitor-1 levels: a possible marker of hypertensive target organ damageEmmanuel J Diamantopoulos, Emmanuel A Andreadis, Charalambos V Vassilopoulos, et al.
Neuroscience Letters|January 22, 2000
Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's diseaseL Lilius, S Froelich Fabre, H Basun, et al.
Pageof 8